S. Kamei et al., Inhibitory properties of human recombinant Arg(24)-> Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2), THROMB RES, 94(3), 1999, pp. 147-152
Human type-2 tissue factor pathway inhibitor (TFPI-2), also known as placen
tal protein 5, is a 32-kDa serine proteinase inhibitor consisting of three
tandemly arranged Kunitz-type domains homologous to tissue factor pathway i
nhibitor. TFPI-2 inhibits a variety of serine proteinases involved in coagu
lation and fibrinolysis through an arginine residue (R24) in its first Kuni
tz-type domain, which constitutes a putative P-1 residue for the substrate
recognition sites of these proteinases. As recent studies have shown that t
his P-1 residue to be a glutamine in murine TFPI-2, we constructed, express
ed, and purified a human TFPI-2 mutant with glutamine substituted for argin
ine at position 24 (R24Q TFPI-2), R24Q TFPI-2 lost similar to 90% of its in
hibitory activity towards bovine trypsin and virtually all inhibitory activ
ity towards human plasmin and the factor VIIa-tissue factor complex, emphas
izing the importance of the P-1 Arg(24) residue in the inhibition of these
serine proteinases. However, whereas wild-type TFPI-2 is a relatively weak
inhibitor of human factor Xa amidolytic activity (IC(50)similar to 1 mu M),
R24Q TFPI-2 exhibited enhanced inhibitory activity towards the amidolytic
and coagulant activities of this proteinase with a K-i of 18 nM. While the
molecular basis for the enhanced inhibition of human factor Xa by R24Q TFPI
-2 is unknown, these data provide suggestive evidence that murine TFPI-2 ma
y function as a serine proteinase inhibitor in spite of the absence of a P-
1 Arg or Lys residue. (C) 1999 Elsevier Science Ltd. All rights reserved.